05/08/2024
3:24 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
3:51 PM | LANGER ROBERT (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:54 PM | Horning Sandra (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:57 PM | Moderna (Issuer)
Tallett Elizabeth E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:59 PM | Moderna (Issuer)
SAGAN PAUL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
4:02 PM | Moderna (Issuer)
Nader Francois (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:42 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/03/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
5:31 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2024
3:21 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/19/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:17 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024
3:23 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
9:58 AM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/12/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:22 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
1:03 PM | Moderna (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
04/09/2024
3:09 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
2:32 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
3:20 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/29/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
3:22 PM | AFEYAN NOUBAR (Reporting)
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/22/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
7:46 AM | Moderna (Filer)
| Form DEF 14A | |
03/21/2024
7:47 AM | Moderna (Filer)
| Form DEFA14A | |
03/19/2024
3:39 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
11:12 AM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
8:30 AM | Moderna (Filer)
| Form ARS | |
03/13/2024
3:24 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
8:05 AM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
2:22 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
2:13 PM | Garay Arpa (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
4:52 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
2:32 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
2:25 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:25 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:29 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:33 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The 2024 Gold Rush: Unleashing Market Potential (Ad) Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights. Get your free information kit NOW, before it's too late. |
02/29/2024
4:28 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
3:49 PM | Garay Arpa (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
3:32 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:37 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:39 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:24 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
3:21 PM | Moderna (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/22/2024
2:39 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024
5:32 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
3:20 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
2:16 PM | Bancel Stephane (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
2:39 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024
7:42 AM | Bancel Stephane (Filed by)
Moderna (Subject)
| Form SC 13G/A | |
01/29/2024
2:26 PM | BlackRock Inc. (Filed by)
Moderna (Subject)
| Form SC 13G/A | |
01/29/2024
9:49 AM | BAILLIE GIFFORD & CO (Filed by)
Moderna (Subject)
| Form SC 13G/A | |
01/08/2024
2:21 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
6:03 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
7:00 AM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
10:37 AM | Hoge Stephen (Reporting)
Moderna (Subject)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
7:04 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
2:24 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/07/2023
3:21 PM | Garay Arpa (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
2:13 PM | Garay Arpa (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023
2:43 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023
2:30 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023
2:35 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023
7:54 AM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023
7:02 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
5:33 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/27/2023
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2023
7:59 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/13/2023
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2023
3:07 PM | Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2023
3:07 PM | AFEYAN NOUBAR (Reporting)
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2023
3:51 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
6:02 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
2:17 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/29/2023
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
3:38 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023
3:06 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
6:28 PM | Bancel Stephane (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
1:16 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
3:14 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023
7:08 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2023
6:01 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
2:38 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023
3:46 PM | Garay Arpa (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The 2024 Gold Rush: Unleashing Market Potential (Ad) Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights. Get your free information kit NOW, before it's too late. |
09/06/2023
3:17 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
2:22 PM | Garay Arpa (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2023
2:45 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2023
2:31 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/01/2023
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2023
3:22 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2023
2:36 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/25/2023
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2023
3:14 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
